These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nuclear factor-kappaB in the liver: friend or foe? Schwabe RF; Brenner DA Gastroenterology; 2007 Jun; 132(7):2601-4. PubMed ID: 17570232 [No Abstract] [Full Text] [Related]
3. Biology and pathobiology of gap junctional channels in hepatocytes. Vinken M; Henkens T; De Rop E; Fraczek J; Vanhaecke T; Rogiers V Hepatology; 2008 Mar; 47(3):1077-88. PubMed ID: 18058951 [TBL] [Abstract][Full Text] [Related]
4. Computational strategies unravel and trace how liver disease changes hepatic drug disposition. Park S; Ropella GE; Kim SH; Roberts MS; Hunt CA J Pharmacol Exp Ther; 2009 Jan; 328(1):294-305. PubMed ID: 18948498 [TBL] [Abstract][Full Text] [Related]
6. miR-122, a paradigm for the role of microRNAs in the liver. Girard M; Jacquemin E; Munnich A; Lyonnet S; Henrion-Caude A J Hepatol; 2008 Apr; 48(4):648-56. PubMed ID: 18291553 [TBL] [Abstract][Full Text] [Related]
7. [Interpretation of morphologic data of normal and pathologic human liver obtained with ultrasonic echoscopy]. Charbonnier A; Cachin M; Perrin J Arch Fr Mal App Dig; 1969 Dec; 58(12):828. PubMed ID: 5400395 [No Abstract] [Full Text] [Related]
8. [Proteoglycans in the liver]. Kovalszky I; Dudás J; Gallai M; Hollósi P; Tátrai P; Tátrai E; Schaff Z Magy Onkol; 2004; 48(3):207-13. PubMed ID: 15520870 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide biology and the liver: report of an AASLD research workshop. Rockey DC; Shah V Hepatology; 2004 Jan; 39(1):250-7. PubMed ID: 14752845 [No Abstract] [Full Text] [Related]
10. [Receptors of hepatic stellate cells: new insights and prospects for therapy]. Shen F; Yin C; Jia J; Wang B Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):479-80. PubMed ID: 12502466 [No Abstract] [Full Text] [Related]
11. PKC signaling in oxidative hepatic damage. Nitti M; Pronzato MA; Marinari UM; Domenicotti C Mol Aspects Med; 2008; 29(1-2):36-42. PubMed ID: 18035409 [TBL] [Abstract][Full Text] [Related]
16. Iron in NASH, chronic liver diseases and HCC: how much iron is too much? Pietrangelo A J Hepatol; 2009 Feb; 50(2):249-51. PubMed ID: 19070915 [No Abstract] [Full Text] [Related]
17. [Use of drugs in reduced liver function]. Spigset O Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2645-6. PubMed ID: 16215611 [No Abstract] [Full Text] [Related]
18. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review. Fischbach F; Bruhn H Liver Int; 2008 Mar; 28(3):297-307. PubMed ID: 18290772 [TBL] [Abstract][Full Text] [Related]
19. Neuropeptide urocortin 1 and its receptors are expressed in the human liver. Simopoulos C; Christodoulou E; Lambropoulou M; Tsaroucha AK; Kakolyris S; Polychronidis A; Karayiannakis AJ; Chatzaki E Neuroendocrinology; 2009; 89(3):315-26. PubMed ID: 19096201 [TBL] [Abstract][Full Text] [Related]